Table 3 Survival probabilities at 28, 60, and 90 days (Kaplan-Meier product limit method) for CD14 rs2569190 polymorphism in septic shock patients who underwent major cardiac or abdominal surgery.

From: Association of CD14 rs2569190 polymorphism with mortality in shock septic patients who underwent major cardiac or abdominal surgery: A retrospective study

Points censoring All Patients CD14 rs2569190 polymorphism
rs2569190 AA/AG rs2569190 GG P-value (log-rank test)
28 days 36.1% 32.9% 45.3% 0.095
60 days 53.2% 50.0% 62.3% 0.035
90 days 55.1% 52.6% 62.3% 0.046
  1. Abbreviations: CD14, cluster of differentiation 14; p-value, level of significance.